• Home
  • About
  • Science
  • Pipeline
  • Team
  • News
  • Contact
  • More
    • Home
    • About
    • Science
    • Pipeline
    • Team
    • News
    • Contact
  • Home
  • About
  • Science
  • Pipeline
  • Team
  • News
  • Contact

Halo Biosciences

Halo Biosciences Halo Biosciences Halo Biosciences

Editing the extracellular matrix to transform disease

Halo Biosciences

Halo Biosciences Halo Biosciences Halo Biosciences

Editing the extracellular matrix to transform disease

Our Mission

Halo is a biotechnology company focused on creating first-in-class, disease-modifying therapies using innovative approaches to edit the extracellular matrix (ECM)






About Halo

Our Science

The ECM in Disease

We are building a differentiated pipeline based on novel insights into how hyaluronan (HA) dysregulation drives disease 


Alterations to HA and to the ECM have strong associations with a variety of conditions characterized by inflammation and fibrosis, including pulmonary hypertension, pulmonary fibrosis, and liver fibrosis

About Our Science

Our Pipeline

A novel approach to ECM editing

Our pipeline is focused on delivering first-in-class and best-in-class hyaluronan remodeling agents, acting on novel targets with a differentiated mechanism of action


Our lead indications are in diseases with high unmet need characterized by inflammation, fibrosis, and immunologic imbalances

Our Pipeline
Meet Our Team

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Halo Biosciences Inc

Stanford, California, United States

Copyright © 2022 Halo Biosciences - All Rights Reserved.